BioDelivery Sciences International, Inc. (NASDAQ:BDSI)
|
4.31 +0.17 (4.11%) Mar 15 - Close |
|
|
|
- Compare BDSI with:
- View: Line | Candlestick
Company Profile
BioDelivery Sciences International, Inc.
801 Corporate Center Drive
Raleigh, -2 27607
United States - Map
Phone: (919) 582-9050
Fax: (919) 582-9051
Website: www.bdsinternational.com
State of incorporation: Delaware
CEO: Dr. Mark A. Sirgo, Pharm.D.
Employees: 20
Sector: Healthcare
Industry Group: Drugs
Industry: Biotechnology
Biopharmaceutical company focused on drug delivery
A specialty pharmaceutical company that is utilizing licensed and owned proprietary drug delivery technologies to develop and commercialize, either on its own or in partnerships with third parties, significant new formulations of proven therapeutics.
Recent news for BDSI
-
BioDelivery Sciences to Present at the 22nd Annual ROTH OC Growth Stock Conference
Business Wire - Mar 09 at 8:00AM (EST)
-
BioDelivery Sciences to Present at the Cowen and Company 30th Annual Health Care Conference
Business Wire - Mar 03 at 8:00AM (EST)
-
EDGAR Online - Mar 01 at 10:50AM (EST)
-
InPlay: BioDelivery plans for three products entering phase 3 next year
Briefing.com - Feb 26 at 8:03AM (EST)
-
BioDelivery Sciences Business Update: Plans for Three Products Entering Phase 3 Next Year
Business Wire - Feb 26 at 8:00AM (EST)
-
BioDelivery Sciences to Host Business Update Conference Call and Webcast on February 25
Business Wire - Feb 18 at 8:00AM (EST)
-
EDGAR Online - Jan 12 at 4:08PM (EST)
-
BDSI eyes $2B market with FDA meeting
bizjournals.com - Jan 12 at 12:05PM (EST)
-
Briefing.com - Jan 12 at 7:01AM (EST)
-
Business Wire - Jan 12 at 7:00AM (EST)
